医学
免疫系统
内科学
肿瘤科
细胞疗法
免疫疗法
子宫颈
癌
阶段(地层学)
胃肠病学
细胞
癌症
免疫学
生物
古生物学
遗传学
作者
Shigenori Goto,Yasuhisa Terao,Takashi Kamigaki,Rishu Takimoto,Keiko Naitoh,Kaori Makita,Kosei Yasumoto,Sachiko Okada,Ken Takizawa,憲幸 横道,Nao Suzuki,Satoru Takeda
出处
期刊:Anticancer Research
[International Institute of Anticancer Research (IIAR) Conferences 1997. Athens, Greece. Abstracts]
日期:2020-07-29
卷期号:40 (8): 4741-4748
被引量:9
标识
DOI:10.21873/anticanres.14475
摘要
BACKGROUND/AIM: We aimed to investigate the efficacy of immune-cell therapy in terms of the survival of patients with neuroendocrine carcinoma of the uterine cervix (NECC), which lacks standardized therapeutic approaches. PATIENTS AND METHODS: We identified 17 patients who were diagnosed as having NECC and treated with immune-cell therapy. The clinical characteristics of these patients were extracted from their records and their overall survival was measured. RESULTS: Of the 17 patients, two patients with early-stage NECC without recurrence and three patients with less than four treatments were excluded. The median survival times from the time of diagnosis and from the initial administration of immune-cell therapy were 49.7 and 24.4 months, respectively. The overall survival rates at 1, 2, and 5 years were 63.6%, 38.2%, and 25.5%, respectively. Long-term survival was observed in the patients with distant metastases. CONCLUSION: The preliminary results of this retrospective study suggested the potential efficacy of immune-cell therapy for NECC.
科研通智能强力驱动
Strongly Powered by AbleSci AI